Arthur J. Higgins has been appointed to Endo Health Solutions’ board of directors. Joseph C. Scodari will retire as a director, effective Dec. 31.

Higgins has over 30 years of domestic and international pharmaceutical industry experience. He currently is a senior advisor to Blackstone Healthcare Partners, the dedicated healthcare team of The Blackstone Group, where he focuses on product-based healthcare acquisitions. Previously, he was chairman of the board of management of Bayer HealthCare and chairman and CEO of Enzon Pharmaceuticals.    

Higgins currently is a senior advisor to Blackstone Healthcare Partners, the dedicated healthcare team of The Blackstone Group, where he focuses on product-based healthcare acquisitions. Previously, Higgins was chairman of the board of management of Bayer HealthCare, a developer and manufacturer of human and animal health products and chairman of the Bayer HealthCare Executive Committee. Higgins was chairman, president and CEO of Enzon Pharmaceuticals from 2001 to 2004. He also spent 14 years with Abbott Laboratories, including as president of the Pharmaceutical Products Division from 1998 to 2001.

Mr. Higgins currently works on the boards of Ecolab, Resverlogix and Zimmer Holdings. He is a past member of the board of directors of the Pharmaceutical Research and Manufacturers of America (PhRMA), of the council of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and president of the European Federation of Pharmaceutical Industries and Associations (EFPIA).